恩考芬尼与西妥昔单抗联合mFOLFOX6一线治疗BRAF V600E 突变转移性结直肠癌的成本-效用分析
朱同明, 易佳, 李文强, 朱啸威, 沈爱宗
Cost‑utility analysis of encorafenib plus cetuximab combined with mFOLFOX6 as first‑line therapy for BRAF V600E‑mutant metastatic colorectal cancer
ZHU Tongming, YI Jia, LI Wenqiang, ZHU Xiaowei, SHEN Aizong
中国医院药学杂志
.
2026, (6): 683
-690
.
DOI: 10.13286/j.1001-5213.2026.06.11
